Regular ophthalmologic examinations should constitute a non-negotiable component of treatment protocols, particularly for patients presenting with diabetes or pre-existing vascular conditions
Supports whole-body health, including gut health, digestion, energy, and immune defense.* NSF Certified for Sport and third-party tested for hundreds of contaminants and banned substances to ensure rigorous quality and safety standards
Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria
For other Novo Nordisk medications, the threshold is 400% FPL (about $60,240 single)